Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation
- PMID: 12890953
- DOI: 10.1159/000071839
Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation
Abstract
Objectives: Subclinical prostatitis is a very frequent histologic finding in pathological examinations of prostate biopsy and prostate surgery material. In this study, we tried to investigate the correlation between the morphological parameters of histological prostatitis and total serum prostate-specific antigen (PSA)-PSA density (PSAD) to determine if either the extent or aggressiveness of inflammation might affect serum PSA.
Methods: 269 patients who had undergone TURP or transvesical prostatectomy with pathological diagnosis of BPH and prostatitis were included in the study. We retrospectively reviewed and scored the extent and aggressiveness of inflammation in prostate specimens of BPH, according to the scale that has been reported by Irani et al. and then correlated those scores with PSA and PSAD.
Results: When the inflammation grades correlated with PSA and PSAD, the extent of the inflammation did not show a significant correlation with total PSA and PSAD (p > 0.05). However, there was a statistically significant correlation between aggressiveness grades and total PSA and PSAD (p < 0.001). Median PSA levels in grades 0, 1 and 2 of aggressiveness of inflammation were 3.2, 4.2 and 5.8 respectively.
Conclusion: Aggressiveness grade of the inflammation in subclinical prostatitis is the most important morphological factor that is responsible for PSA elevation. We believe that it should be a more accurate guide for the clinician if pathologists report on the aggressiveness grades of the inflammation, especially on initial prostate biopsies, in order to help for timing of the further biopsy.
Copyright 2003 S. Karger AG, Basel
Similar articles
-
Prostatitis and serum prostate-specific antigen.Curr Urol Rep. 2005 Jul;6(4):307-12. doi: 10.1007/s11934-005-0029-y. Curr Urol Rep. 2005. PMID: 15978235 Review.
-
[Aggressiveness and extent of prostatic inflammation relates with serum PSA levels in type IV prostatitis].Zhonghua Nan Ke Xue. 2012 Aug;18(8):710-4. Zhonghua Nan Ke Xue. 2012. PMID: 22934516 Chinese.
-
Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density.Eur Urol. 2000 Apr;37(4):404-12. doi: 10.1159/000020161. Eur Urol. 2000. PMID: 10765070
-
The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis.Int Urol Nephrol. 2007;39(3):859-63. doi: 10.1007/s11255-006-9125-2. Epub 2006 Nov 17. Int Urol Nephrol. 2007. PMID: 17111077
-
Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis.Curr Urol Rep. 2009 Jul;10(4):302-6. doi: 10.1007/s11934-009-0049-0. Curr Urol Rep. 2009. PMID: 19570492 Review.
Cited by
-
Can expressed prostatic secretions effect prostate biopsy decision of urologist?Int Braz J Urol. 2019 Mar-Apr;45(2):246-252. doi: 10.1590/S1677-5538.IBJU.2018.0292. Int Braz J Urol. 2019. PMID: 30648827 Free PMC article.
-
Analysis of repeated 24-core saturation prostate biopsy: Inverse association between asymptomatic histological inflammation and prostate cancer detection.Oncol Lett. 2016 Aug;12(2):1132-1138. doi: 10.3892/ol.2016.4693. Epub 2016 Jun 9. Oncol Lett. 2016. PMID: 27446407 Free PMC article.
-
Antibacterial therapy improves the effectiveness of prostate cancer detection using prostate-specific antigen in patients with asymptomatic prostatitis.Int Urol Nephrol. 2010 Mar;42(1):13-8. doi: 10.1007/s11255-009-9598-x. Epub 2009 Jun 23. Int Urol Nephrol. 2010. PMID: 19548108
-
Prostatitis and serum prostate-specific antigen.Curr Urol Rep. 2005 Jul;6(4):307-12. doi: 10.1007/s11934-005-0029-y. Curr Urol Rep. 2005. PMID: 15978235 Review.
-
Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study.Prostate Cancer Prostatic Dis. 2016 Jun;19(2):180-4. doi: 10.1038/pcan.2015.66. Epub 2016 Jan 19. Prostate Cancer Prostatic Dis. 2016. PMID: 26782712
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous